Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-31 · accession 0001437749-22-000291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-04 | 2021-12-31 | BKYI | LACOUS MIRA K | CTO | A - Grant | $1.88 | +2,500 | 6,625 | +61% | +$4,700 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | A | A | 2,500 | $1.88 | 6,625 | D | — | — | (F2) Holdings do not include options to purchase 16,668 shares. |